Holista Colltech Limited

Equities

HCT

AU000000HCT4

Biotechnology & Medical Research

Market Closed - Australian S.E. Other stock markets 06:23:42 03/06/2024 am IST			5-day change	1st Jan Change
0.005 ^AUD	0.00%		0.00%	-50.00%

24/05	Holista Colltech Receives Payment Terms From Federal Court	MT
15/05	Holista Colltech Extends Voluntary Suspension to May 22	MT

Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2020

February 26, 2021 at 04:42 am IST

Holista CollTech Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was AUD 7.106 million compared to AUD 7.257 million a year ago. Net loss was AUD 5.440 million compared to AUD 689,851 a year ago. Basic loss per share from continuing operations was AUD 0.0202 compared to AUD 0.0029 a year ago.

Latest news about Holista Colltech Limited

Holista Colltech Receives Payment Terms From Federal Court	24/05	MT
Holista Colltech Extends Voluntary Suspension to May 22	15/05	MT
Holista Colltech Requests for Extension of Voluntary Suspension	17/04	MT
Holista Colltech Suspended from Australian Bourse Pending Announcement	21/03	MT
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Holista Colltech's Customer Receipts Hit AU$1.8 Million in Q4	31/01	MT
Holista Colltech Says Civil Penalty Federal Court Hearings Completed; Shares Climb 17%	08/12	MT
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/23/31	CI
Olista Colltech Limited Announces Board Changes	06/23/06	CI
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	31/23/31	CI
Holista Colltech Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2022	30/22/30	CI
Holista Colltech's Sales Receipts Jump 55% in Q2	28/22/28	MT
Holista Colltech Limited Announces Test Results on All-Natural Nano Silver Disinfectant	29/22/29	CI
Holista Colltech Receives First Commercial Order from Country Farms	21/22/21	MT
Holista Colltech Limited Auditor Raises 'Going Concern' Doubt	30/22/30	CI
Holista CollTech Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
Holista Colltech's Sanitizer Product Demonstrates 12-Hour Effectivity	29/21/29	MT
Holista Colltech's Cash Receipts Rise in Q3	29/21/29	MT
Holista Colltech Limited Announces Natshield Test Results	29/21/29	CI
Holista Colltech : Secures Trademark Nod From Chinese Regulator	16/21/16	MT
Holista CollTech Limited Announces Change of Company Secretary	01/21/01	CI
Holista Colltech Limited Announces Change of Registered Office	01/21/01	CI
Holista Colltech Limited Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Holista CollTech : Corporate Regulator Sues Holista Colltech over Misleading Statements	05/21/05	MT

Chart Holista Colltech Limited

Duration

Period

More charts

Company Profile

Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company operates through four segments: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Companyâs products include LOGIC Sweet, Super Bio Silver, OVICOLL, OVINEX, low-GI bread, low-GI noodle and spaghetti, 80Less sugar, Low Fat Chip, and health supplements. The Company's subsidiaries include Holista Biotech Sdn Bhd, Alterni (M) Sdn Bhd, Revonutrix Sdn Bhd, and others.

Sector

Biotechnology & Medical Research

Calendar

30/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HOLISTA COLLTECH LIMITED	-50.00%	926K
MODERNA, INC.	+55.70%	59.34B
LONZA GROUP AG	+42.95%	40.24B
IQVIA HOLDINGS INC.	-5.26%	39.88B
CELLTRION, INC.	-5.56%	28.55B
ICON PUBLIC LIMITED COMPANY	+16.34%	27.26B
ALNYLAM PHARMACEUTICALS, INC.	-21.05%	19.23B
MEDPACE HOLDINGS, INC.	+32.26%	12.61B
BIO-TECHNE CORPORATION	+3.45%	12.49B
UNITED THERAPEUTICS CORPORATION	+26.29%	12.28B

Other Biotechnology & Medical Research